May 30 2008
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has closed the acquisition of The Polymer Technology Group, Inc. (PTG) of Berkeley (California, United States), a market leader in the field of biomedical polymers.
Through this acquisition DSM gains a global leading position in the fast growing biomedical materials market. PTG will now be known as DSM PTG. The acquisition was announced on 28 April 2008.
Steve Hartig, President DSM Biomedical, commented: “We are excited that our acquisition of PTG has closed and look forward to moving forward with a combined effort. With PTG, DSM obtains a leading position in the field of biomedical polymers. This acquisition will enable us to grow a unique portfolio of materials-based technologies for the healthcare market. This will allow acceleration in our business growth and market presence.”
Bob Ward, President and one of the founders of PTG: “We see the combination of PTG and DSM’s biomedical activities as a huge step allowing us to better serve our customers in the medical device and pharmaceutical industries by bringing a much greater breadth of products, technology and services to bear.”
The DSM Biomedical and PTG organization will be closely linked to best service the global market. To secure a smooth integration Bob Ward will stay on as President of DSM PTG.
The acquisition of PTG is an important step for DSM in realizing its ambitions in Biomedical Materials, one of the Emerging Business Areas defined in DSM’s Vision 2010 strategy. Being active in both Materials Sciences and Life Sciences, DSM is in a unique position and can combine its abilities in both market segments resulting in new, innovative products that address societal needs in this particular case in healthcare.